Drug name - Lazanda

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9078814 BTCP PHARMA Intranasal spray device containing pharmaceutical composition Jan, 2024

(1 year, 3 months from now)

US9814705 BTCP PHARMA Intranasal spray device containing pharmaceutical composition Jan, 2024

(1 year, 3 months from now)

US8889176 BTCP PHARMA Method of managing or treating pain Jan, 2024

(1 year, 3 months from now)

US8216604 BTCP PHARMA Method of managing or treating pain Oct, 2024

(2 years from now)

US9731869 BTCP PHARMA Container Jan, 2032

(9 years from now)

Drugs and Companies using FENTANYL CITRATE ingredient

Treatment: Management of breakthrough pain in patients with cancer

Dosage: SPRAY, METERED;NASAL

More Information on Dosage
Strength Dosage Availability
EQ 0.1MG BASE SPRAY, METERED;NASAL Prescription
EQ 0.3MG BASE SPRAY, METERED;NASAL Discontinued
EQ 0.4MG BASE SPRAY, METERED;NASAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.